DrJaguar8
reacted to
⚠️READ THIS BEFORE YOU TRADE ⚠️
1. NFA — Nothing here is financial advice. I am not your financial advisor, and this is NOT a buy/sell alert.
2. Trade with confirmation. Always check the chart, volume, momentum, order book, and short availability before touching a position.
3. Manage risk like a pro. Scale out, take profits, use stops. If you’re guessing instead of planning, you’re gambling.
4. Your P&L is yours. Wins are yours to celebrate, loss...
1. NFA — Nothing here is financial advice. I am not your financial advisor, and this is NOT a buy/sell alert.
2. Trade with confirmation. Always check the chart, volume, momentum, order book, and short availability before touching a position.
3. Manage risk like a pro. Scale out, take profits, use stops. If you’re guessing instead of planning, you’re gambling.
4. Your P&L is yours. Wins are yours to celebrate, loss...
+8
36
7
2
DrJaguar8
reacted to and commented on
Just sharing this respectfully as a user and trader.
I understand that every platform has to manage risk, and I’m not against that. What I hope for is a little more clarity when trading access changes on certain stocks, especially when some of these names have been available for a long time.
For retail traders, consistency matters a lot. We plan entries, exits, and risk based on what we believe is tradable. So when a ticker is suddenly restricted, it can be confusing and frustrat...
I understand that every platform has to manage risk, and I’m not against that. What I hope for is a little more clarity when trading access changes on certain stocks, especially when some of these names have been available for a long time.
For retail traders, consistency matters a lot. We plan entries, exits, and risk based on what we believe is tradable. So when a ticker is suddenly restricted, it can be confusing and frustrat...
99
23
DrJaguar8
commented on
$DarkIris (DKI.US)$ hello master @DrJaguar8 there is movements today afterhour , do you think there is continuation next monday ? ![]()
![]()
![]()
6
DrJaguar8
reacted to and commented on
$Xiao-I (AIXI.US)$ 59.29%
$iSpecimen (ISPC.US)$ 37.14%
$Lianhe Sowell International (LHSW.US)$ 16.67%
$XCF Global (SAFX.US)$ 77.76%
$U Power (UCAR.US)$ 62.57%
$iSpecimen (ISPC.US)$ 37.14%
$Lianhe Sowell International (LHSW.US)$ 16.67%
$XCF Global (SAFX.US)$ 77.76%
$U Power (UCAR.US)$ 62.57%
16
8
$Cue Biopharma (CUE.US)$
Cue Biopharma Receives $7.5M Milestone Payment From Boehringer Ingelheim
Cue Biopharma Receives $7.5M Milestone Payment From Boehringer Ingelheim
$Allogene Therapeutics (ALLO.US)$
Allogene Therapeutics to Announce Interim Futility Analysis Data From Its Pivotal Phase 2 ALPHA3 Trial With Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation LBCL on Monday, April 13, 2026
SOUTH SAN FRANCISCO, Calif., April 10, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for cancer and autoimmune disease, today ...
Allogene Therapeutics to Announce Interim Futility Analysis Data From Its Pivotal Phase 2 ALPHA3 Trial With Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation LBCL on Monday, April 13, 2026
SOUTH SAN FRANCISCO, Calif., April 10, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for cancer and autoimmune disease, today ...
6
DrJaguar8
commented on
2
2
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,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)
DrJaguar8 OP Barbarian Zheng : I won’t use Moomoo tools if i leave.
DrJaguar8 OP Josam456 : I have WeBull and trade there too but also has restrictions. Moving likely to IBKR
DrJaguar8 OP mrmark : a platform
DrJaguar8 OP a菠萝 : The interactive experience is useless if one is not able to trade so many stocks
DrJaguar8 OP Kimj00 : IBKR has no community chat
View more comments...